The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase II trial of systemic chemotherapy with or without trastuzumab followed by surgery in HER2 positive advanced gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: 3-year follow-up data of the Japan Clinical Oncology Group study JCOG1301C (Trigger study).
 
Masaki Aizawa
Honoraria - Bristol Myers Squibb Foundation; Johnson & Johnson/MedTech; Medtronic; MSD; Ono Pharmaceutical; Taiho Pharmaceutical
 
Masanori Tokunaga
Honoraria - Astellas Pharma; Daiichi Sankyo; Intuitive Surgical; Johnson & Johnson; Lilly Japan; Medtronic; Olympus Medical Systems; Ono Pharmaceutical; Ono Pharmaceutical; Taiho Pharmaceutical
 
Nozomu Machida
Honoraria - Astellas Pharma; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Lilly Japan; Merck KGaA; MSD K.K; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - ALX Oncology (Inst); Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb Japan (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Riku Kajikawa
No Relationships to Disclose
 
Noriko Mitome
No Relationships to Disclose
 
Motohiro Hirao
No Relationships to Disclose
 
Masato Nishida
No Relationships to Disclose
 
Takahiro Kinoshita
Honoraria - Bristol-Myers Squibb Japan; Daiichi Sankyo; Gunze; Intuitive Surgical; Johnson & Johnson; Kaken Pharmaceutical; Medtronic; MSD; Olympus Medical Systems; Ono Pharmaceutical; Smart hospital; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Bristol-Myers Squibb Japan; Daiichi Sankyo; Johnson & Johnson K.K; Medtronic; Olympus Medical Systems; Ono Pharmaceutical; Otsuka; Taiho Pharmaceutical; Tsumura & Co.
 
Atsushi Yasuda
No Relationships to Disclose
 
Tomono Kawase
No Relationships to Disclose
 
Mikihiro Kano
No Relationships to Disclose
 
Yukinori Kurokawa
Honoraria - Astellas Pharma; Daiichi Sankyo; Johnson & Johnson; Lilly; MC Medical; Medtronic; MSD; Nippon Kayaku; Ono Pharmaceutical; Stryker; Taiho Pharmaceutical; Yakult Honsha
Consulting or Advisory Role - Astellas Pharma; Taiho Pharmaceutical
Research Funding - AstraZeneca (Inst); MSD Oncology (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Yakult Honsha (Inst)
 
Narikazu Boku
Honoraria - Bristol-Myers Squibb Japan; Daiichi-Sankyo; Lilly; Ono Pharmaceutical; Taiho Pharmaceutical
 
Takaki Yoshikawa
Honoraria - Astellas Pharma; AstraZeneca; BMS; Chugai Pharma; Daiichi Sankyo; Intuitive Surgical; Johnson & Johnson/Janssen; Medtronic; Olympus; Ono Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - MSD Oncology; TERUMO
Research Funding - Lilly
 
Masanori Terashima
Honoraria - Bristol-Myers Squibb; Daiichi Sankyo; Intuitive Surgical; Johnson & Johnson; Lilly; Olympus; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Honsha
 
Japan Clinical Oncology Group
No Relationships to Disclose